13F

Stock

Alnylam Pharmaceuticals, Inc.

ALNY · held by 5 managers

Reported value

$48.3M

Holders

5

+0 new · −0 exited

Holders’ est. mark

$1.42M

Price effect on 3 books still in the name

Largest holder

$38.5M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC162.1K$38.5MHeld
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main35.4K$8.41M$1.33MAdded$1.33M
Swiss Life Asset Management Ltd4K$953.3K$67.7KAdded$601.4K
Marex Group plc992$235.7KHeld
Leonteq Securities AG613$145.7K$23KCut−$82.1K

Positions as of Q4 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.